Applied Genetic Technologies reported $3.68M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Alimera Sciences ALIM:US $ 8.56M 128K
Applied Genetic Technologies AGTC:US $ 3.68M 207K
Avrobio Inc AVRO:US 9.58M 746K
Biogen BIIB:US $ 654.1M 16.8M
Bluebird Bio BLUE:US $ 68.28M 10.3M
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Cti Biopharma CTIC:US $ 13.66M 3.45M
Gilead Sciences GILD:US $ 1.18B 173M
Insmed INSM:US $ 60.28M 3.1M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Life Technologies LIFE:US $ 2.59M 200K
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K